AzTrials
AzTrials

Nasal Septal DeviationNCT04579042

Cartilaginous Batten Graft Septoplasty in Caudal Septal Deviation

A study testing cartilaginous batten graft septoplasty in people with Nasal Septal Deviation, run by Benha University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To evaluate the clinical outcomes of septoplasty using cartilaginous batten graft in cases with caudal septal deviation as regards the relieve of nasal obstruction and aesthetic results. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Nasal Septal Deviation
What is being tested?
cartilaginous batten graft septoplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
7 Oct 2020to 1 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient presented with nasal obstruction or disfigurement due to anterocaudal septal deviation.

Who cannot join

  • Previous septal surgery
  • Deformed nose, which necessitate external rhinoplasty approach.
  • Other endonasal cause of nasal obstruction other than deviated nasal septum
  • Bleeding disorder or systemic diseases.
  • Patient who will not complete the follow up periods.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Benha University Hospital, Faculty of Medicine

    Banhā, Qalyubia Governorate, 13512

Other trials in Egypt

About this study

Official title: Clinical Outcomes After Septoplasty Using Cartilaginous Batten Graft in The Management of The Caudal Septal Deviation

To evaluate the clinical outcomes of septoplasty using cartilaginous batten graft in cases with caudal septal deviation as regards the relieve of nasal obstruction and aesthetic results.

Read the detailed description

A prospective study will be conducted over 15 patients indicated for septoplasty.

Preoperative assessment:

History

  • NOSE (nasal obstruction septoplasty effectiveness score): Higher NOSE scores indicate worse nasal obstruction (range: 0-100).
  • Visual analogue scale (VAS) (0-10) of nasal obstruction:For nasal obstruction

Examination:

  • Anterior rhinoscopy: to confirm caudal septal deviation.
  • Endoscopic nasal examination: to exclude HIT, polyp, mass and discharge.
  • Basal view photograph.
  • CT nose and paranasal sinuses to exclude other pathology.

Operative procedures:

  • General anesthesia.
  • Hemitransfixtion incision on the concave side
  • The mucoperichondrial flap of the septum will be elevated
  • A contralateral flap will be elevated from the caudal aspect of the cartilage
  • Subperichondrial dissection into the nasal floor
  • The curved portion of the septal cartilage will be harvested by excision, leaving an L-strut of dorsal and caudal cartilaginous septum
  • A caudal septal batten graft created from harvested septal cartilage, then will be sutured using three or four stitches (5-0 polydioxanone sutures).
  • If C-shaped caudal deviation without angulation or dislocation, cartilaginous batten graft fixed on the concave side
  • If there is angulation of caudal septal end, the caudal strut will be cut by scissors at the most convex point in the caudocephalic direction. Excessive lower and upper caudal struts will be overlapped and sutured together with batten graft
  • If dislocated, the septal cartilage will be separated from the anterior nasal spine (ANS) and maxillary crest for reposition. If there is an excessive cartilage portion, it will be removed and then the graft will be sutured
  • The hemitransfixion incision will be closed using 5-0 Vicryl
  • Internal nasal splint and anterior nasal pack will be placed in both sides
Being tested
cartilaginous batten graft septoplasty
Keywords
Caudal septal deviation, Batten graft, Septoplasty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cartilaginous batten graft septoplastyProcedure or surgery

    Also called batten graft septoplasty

    septoplasty using cartilaginous batten graft in cases with caudal septal deviation

Study groups in NCT04579042
Study groupRoleWhat they receive
Septoplasty Using Cartilaginous Batten GraftExperimentalseptoplasty using cartilaginous batten graft in cases with caudal septal deviation
Receives: Procedure: cartilaginous batten graft septoplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nasal obstruction

    We will use the validated Nasal obstruction septoplasty effectiveness score: (range: 0-100) Higher NOSE scores indicate worse nasal obstruction.

    Measured: 3 months

Secondary outcomes (1)
  1. Aesthetic results

    Basal view photography:

    Two independent observers will review the photographs and 4-point grading system will be used to evaluate results:

    • Grade I: Will indicate that the patient has little or no photographic evidence of residual caudal septal deviation.
    • Grade II: The caudal septal deviation show marked improvement but still detectable by careful observation.
    • Grade III: The caudal deviation is only mildly improved or not improved from the preoperative assessment.
    • Grade IV: The caudal deviation is worse after surgical intervention

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2020
  2. Study start7 Oct 2020
  3. Primary completion1 Jan 2023
  4. Study completion1 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04579042
Sponsor's protocol ID
MS 40-1-2020
Status last verified
Mar 2023
First submitted
1 Oct 2020
Last updated
6 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg. 2004 Feb;130(2):157-63. doi: 10.1016/j.otohns.2003.09.016.

    PubMed 14990910
  • Chung YS, Seol JH, Choi JM, Shin DH, Kim YW, Cho JH, Kim JK. How to resolve the caudal septal deviation? Clinical outcomes after septoplasty with bony batten grafting. Laryngoscope. 2014 Aug;124(8):1771-6. doi: 10.1002/lary.24491. Epub 2013 Dec 9.

    PubMed 24323627

Questions about this trial

What is this clinical trial studying?

A study testing cartilaginous batten graft septoplasty in people with Nasal Septal Deviation, run by Benha University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nasal obstruction (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04579042, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in